Mechanistically, NEU4 can remove α-2,3-sialic acids from the end of the oligosaccharide chains on the CD44, resulting in enhanced cell-matrix adhesion and consequent suppression of HCC metastasis both in vitro and in vivo [57]. This evidence concerns the gene NEU4 and hepatocellular carcinoma.